A Stalled Revolution? Misoprostol and the Pharmaceuticalization of Reproductive Health in Francophone Africa
Misoprostol entered the global market under the name Cytotec in the mid-1980s for the treatment of gastric ulcers. Decades of research have since demonstrated the safety and effectiveness of off-label use of misoprostol as a uterotonic in pregnant women to prevent and treat post-partum hemorrhage, t...
Main Author: | Siri Suh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Sociology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fsoc.2021.590556/full |
Similar Items
-
Letrozole and misoprostol versus misoprostol alone for termination of pregnancy: a randomized clinical trial
by: Zahra Rezai, et al.
Published: (2014-02-01) -
Early Medical Abortion with Stachys lavandulifolia Hydroalcoholic Extract in Eombination with Misoprostol Compared to Misoprostol Alone: A Randomized Clinical Trial
by: SH Aramesh, et al.
Published: (2023-12-01) -
Methotrexate and Misoprostol against Misoprostol Alone for Early Medical Abortion: Comparative Study
by: Engy M. Taher, et al.
Published: (2014-06-01) -
The biomedicalisation of illegal abortion: the double life of misoprostol in Brazil
by: Silvia De Zordo -
Aborto provocado: redução da frequência e gravidade das complicações. Consequência do uso de misoprostol? Artificial abortion: is reduction in the frequency and severity of complications a result of the use of misoprostol?
by: Daniela Fornel de Oliveira Silva, et al.
Published: (2010-12-01)